Rocket Pharmaceuticals said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/rocket-pharmaceuticals-withdraws-us-application-blood-2025a1000qlr?src=rss
Author :
Publish date : 2025-10-03 11:11:00
Copyright for syndicated content belongs to the linked Source.